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Synthesis of N-[(dialkylamino)methyl]acrylamides
and N-[(dialkylamino)methyl]methacrylamides
from Schiﬀ base salts: useful building blocks for
smart polymers†
Abdullah Alzahrani, Styliana I. Mirallai, * Benjamin A. Chalmers, Patrick McArdle
and Fawaz Aldabbagh *‡
The traditional thermal Mannich reaction is unsuitable for preparing polymerizable N-methylene amino
substituted acrylamides and methacrylamides. Herein we provide a facile multi-gram high yield synthesis
of these monomeric precursors to stimuli-responsive polymers by the addition of acrylamides and
methacrylamides onto in situ generated or freshly isolated methylene Schiﬀ base (iminium) salts. The
X-ray crystal structure of the hydrated iminium salt, 1-(hydroxymethyl)azocan-1-ium chloride and
monomer·HCl salt (N-[(azocan-1-yl)methyl]prop-2-enamide hydrochloride) is described.
Introduction
The three-component Mannich reaction is fundamental, allow-
ing access to β-amino methylated carbonyl compounds.1,2
N-[(Dialkylamino)methyl]acrylamide and methacrylamide ana-
logues are valuable monomeric precursors to smart polymers,
with dual functionalities of temperature and pH-responsive-
ness (Fig. 1), however potential applications have not been
realised due to problems with their synthesis.
Literature routes have used one-pot Mannich condensation
of (meth)acrylamide with formaldehyde to generate the Schiﬀ
base followed by secondary amine addition (Scheme 1).3–6 The
reaction operates thermally (at ∼80 °C), and is ineﬃcient in
forming the Schiﬀ base in situ, with the elevated temperature
resulting in premature polymerization of the monomer and
intermediates. The reaction has the added diﬃculty of
monomer isolation, which requires vacuum distillation from
the aqueous reaction mixture.
The most widely studied temperature-responsive polymers
are those with lower critical solution temperature (LCST)
close to physiological temperature, such as poly(N-isopropyl-
acrylamide) and poly(N,N-diethylacrylamide) with LCST of
32–34 °C in water.7–9 The N-dialkyl amino (including saturated
nitrogen heterocycle) of substituted acrylamides and methacryl-
amides can be reversibly ionized allowing for a pH-response
that alters polymer hydrophobicity.9–15 Amphiphilic block
copolymers comprising such monomers can self-assemble
into a variety of nano-objects for use as stimuli-responsive
Fig. 1 (a) Synthetic targets and (b) precursors.
Scheme 1 One-pot thermal Mannich reaction route.
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polymersomes for targeted delivery of therapeutics.11–13 In a
recent communication, the synthesis of the selected acryl-
amides containing N-methylene saturated nitrogen hetero-
cycles, and their incorporation into well-defined water-soluble
block copolymer polyacrylamides was realised.14 In this full
paper, we expand on the monomer synthesis by providing
eﬃcient multi-gram routes to acrylamides and methacryla-
mides, including those with dialkyl acyclic and large saturated
nitrogen heterocyclic rings. The synthesis involves eﬃcient
generation of the methylene Schiﬀ base salt, which was charac-
terized in the hydrated form.
Results and discussion
In contrast to the one-pot thermal Mannich condensation reac-
tion in Scheme 1, our synthesis uses readily accessible aminals
made from the condensation of formaldehyde with secondary
amines at 0 °C (Scheme 2).16,17 Böhme pioneered the quaterni-
zation of the aminal to generate the Schiﬀ base (iminium) salt,
and this procedure using acetyl chloride was followed.17,18
There are numerous accounts of alkylation and nucleophilic
addition onto methylene Schiﬀ base salts,16–28 including by
non-vinylic amides.27,28 The most utilised is commercial N,N-
dimethylmethyleneiminium iodide or Eschenmoser’s salt.20,29
Inspired by the simplicity and low temperatures, acrylamides
and methacrylamides were added onto in situ generated
methylene Schiﬀ salts to give the monomer hydrochloride
salts of morpholine, pyrrolidine and piperidine.
The monomer hydrochloride salts 1a·HCl–3b·HCl were pre-
cipitated upon the addition of diethyl ether to the reaction in
acetonitrile, which allowed the separation of the soluble
N-acetyl cycloamines (Scheme 2). The isolable 1a·HCl–3b·HCl
salts are themselves useful as monomeric building blocks in
aqueous solution polymerizations.14 Basification of the latter
allowed the free N-[(cycloalkylamino)methyl]acrylamides 1a–3a
to be isolated on a 20–25 g scale in yields of 66–75% with the
N-[(cycloalkylamino)methyl]methacrylamides 1b–3b isolated
in higher yields of 82–92% and on a ≥30 g scale.
Our in situ Schiﬀ base salt approach was not applicable for
larger cycloamines (azepane and azocane) and acyclic ana-
logues. Isolation of the methylene Schiﬀ base salts was
deemed necessary in these cases due to the poor solubility of
their aminals in acetonitrile. Seven and eight-membered
heterocyclic base-containing monomers are useful for
increased hydrophobicity in the ionisable block segment of
amphiphilic copolymers promoting sharper pH-sensitivity of
micelles.11,12 In contrast, linear dialkyl amine-containing poly-
acrylamides generally have greater water solubility in compari-
son to heterocyclic amine-containing analogues aﬀording
higher LCSTs.10 Treatment of the aminals with acetyl chloride
in diethyl ether at 0 °C allowed access to both larger hetero-
cyclic and acyclic methylene Schiﬀ base salts 4a–4f, which
were more conveniently characterised as N-hydroxymethyl
hydrochloride salt derivatives 5a–5f (Scheme 3).
NMR spectra of iminium salts 4a–4f showed mixtures with
their respective hydrated derivatives 5a–5f. For example, the
1H-NMR spectrum in CD2Cl2 gave similar intensity signals for
the exo-methylene of N-methylideneazocan-1-ium chloride (4b)
at 8.87 ppm and its N-hydroxymethyl derivative 5b exo-methyl-
ene at 4.74 ppm (Fig. 2a). Upon recrystallization from aceto-
nitrile, the more stable N-(hydroxymethyl)azocan-1-ium chlor-
ide 5b was obtained (Fig. 2b). It was thus more convenient to
characterize the moisture sensitive methylene Schiﬀ base salts
4a–4f using NMR in D2O, as 5a–5f (Fig. 2c). An exception was
N,N-dibutylmethaniminium chloride (4f ), which appeared less
hygroscopic. The NMR spectrum in CD2Cl2 contained only
trace amounts of hydrated derivative 5f (Fig. 3a). The exo-
methylene at 8.58 ppm in CD2Cl2 for the methylene Schiﬀ
Scheme 2 Synthesis of N-[(cycloalkylamino)methyl]acrylamides 1a–
3a,14 and N-[(cycloalkylamino)methyl]methacrylamides 1b–3b using the
in situ Schiﬀ base salt approach.
Scheme 3 Synthesis of methylene Schiﬀ base salts 4a–4f characterised
by 1H NMR as hydrated derivatives 5a–5f.
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base was replaced by the exo-methylene at 4.83 ppm in D2O for
N-butyl-N-(hydroxymethyl)butan-1-aminium chloride (5f in
Fig. 3b).
The X-ray crystal structure of N-(hydroxymethyl)azocan-1-
ium chloride (5b) was obtained (Fig. 4a, Table S1†). The large
eight membered ring of 5b was found to be disordered over
two equally populated sites with both the N–H and O–H bonds
found to be involved in H-bonding to the chloride counter ion
(Fig. 4b). Interestingly, a search of the CCDC database for the
R2NH–CH2–OH moiety gave only one hit, CSD code DIVDET,
which was for a pyrimidine salt of tris(hydroxymethyl)
ammonium chloride.30 The hydroxymethyl hydrochlorides 5a–
5f were however diﬃcult to isolate cleanly due to their suscep-
tibility to decompose to formaldehyde.
Nucleophilic addition of acrylamides or methacrylamides
onto the freshly prepared methylene Schiﬀ base salts of
azepane and azocane 4a and 4b gave the hydrochloride
monomer salts (6a·HCl, 6b·HCl, 7a·HCl and 7b·HCl) after pre-
cipitation from diethyl ether (Scheme 4). The monomer HCl
salts were suspended in dichloromethane and basified to give
the monomers 6a–6b and 7a–7b in high yields of 84–91%
(from 4a–4b). Attempts to react acrylamide and methacryl-
amide with an analytically pure sample of N-(hydroxymethyl)
azocan-1-ium chloride (5b) in dried acetonitrile resulted in the
isolation of unreacted 5b and some degradation with the
release of formaldehyde. It follows that yields of the monomer
from addition onto methylene Schiﬀ base salts were deter-
mined by the extent of hydration of the latter substrate.
The X-ray crystal structure of N-[(azocan-1-yl)methyl]prop-2-
enamide hydrochloride (7a·HCl) was obtained with very small
fitting errors suggesting that the ring was in the optimal con-
formation (Fig. 5). The crystal structure showed N–H bonds
forming H-bonding interactions with the chloride anions and
the oxygen atoms resulting in intermolecular packing with
some weaker C–H⋯Cl and C–H⋯O (see Fig. S1, S2 and
Table S2†).
For the preparation of N-dialkyl amino substituted mono-
mers, N-[(dialkylamino)methyl]acrylamides 8a–11a and
N-[(dialkylamino)methyl]methacrylamides 8b–11b, freshly pre-
Fig. 2 1H-NMR spectrum: (a) of the initially isolated mixture containing
N-methylideneazocan-1-ium chloride (4b) and N-(hydroxymethyl)
azocan-1-ium chloride (5b) in CD2Cl2 and spectra after recrystallization
from MeCN in (b) CD2Cl2, and (c) D2O.
Fig. 3 1H-NMR spectrum: (a) of N,N-dibutylmethaniminium chloride
(4f ) in CD2Cl2 and (b) of N-butyl-N-(hydroxymethyl)butan-1-aminium
chloride (5f ) in D2O.
Scheme 4 Synthesis of seven and eight-membered N-[(cycloalkyla-
mino)methyl]acrylamides 6a–7a and N-[(cycloalkylamino)methyl]
methacrylamides 6b–7b from the freshly prepared methylene Schiﬀ
base salts.
Fig. 4 The X-ray crystal structure of N-(hydroxymethyl)azocan-1-ium
chloride (5b): (a) only one component of the ring disorder shown for
clarity and (b) H-bonding interactions (Table S1†).
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pared acyclic Schiﬀ base salts 4c–4f were reacted with acryl-
amides and methacrylamides in acetonitrile at room tempera-
ture (Scheme 5). In this case, the isolation of the N-dialkyl
amino substituted monomer hydrochloride salts proved
diﬃcult due to appreciable solubility in the reaction solvent
and attempted precipitation solvents (including diethyl ether).
Thus basification of the reaction mixture was preferred and
the free monomer bases were isolated in multi-gram quantities
(22–49 g) in yields of 69–90% without the isolation of the inter-
mediate salts.
Conclusions
Readily accessible methylene Schiﬀ base (iminium) salts have
allowed the preparation of eighteen previously inaccessible
acrylamides and methacrylamides containing methylene
N-amino groups (both heterocyclic and acyclic). Heterocyclic
substituted monomer syntheses have the added advantage of
allowing the isolation of the monomer hydrochloride salt
intermediate useful for polymerizations in water. For the
preparation of monomers substituted with azepane, azocane,
and acyclic derivatives, the iminium salts should be first iso-
lated, prior to reactions with acrylamides and methacryla-
mides. Syntheses occur at low or ambient temperatures avoid-
ing premature polymerization of vinyl compounds. Iminium
salts are however hygroscopic and X-ray crystal structures of
the hydrated eight-membered Schiﬀ base salt, 1-(hydroxy-
methyl)azocan-1-ium chloride (5b), and the related monomer,
N-[(azocan-1-yl)methyl]prop-2-enamide hydrochloride (7a·HCl)
are described. Future research will involve controlled radical
polymerizations of this new vinyl monomer class to give
amphiphilic block copolymers for use as smart stimuli (temp-
erature, pH, CO2)-responsive materials.
Experimental
General information
Melting points were measured on a Stuart Scientific
SMP1 melting point apparatus. Infrared spectra were recorded
using a PerkinElmer Spec 1 with ATR attached. 1H NMR
spectra were recorded at 400 or 500 MHz and 13C NMR were
recorded at 101 or 125 MHz using a 400 MHz JEOL ECX and a
500 MHz Varian instrument respectively. The chemical shifts
were recorded in ppm relative to Me4Si. NMR assignments
were supported by DEPT. Deuterated solvents were used for
homonuclear lock, and the signals were referenced to the
deuterated solvent peaks. 1,4-Dioxane was used as a reference
for 13C NMR in D2O. High resolution mass spectra (HRMS)
were recorded using an ESI time-of-flight mass spectrometer
(TOFMS) in positive mode. The precision of all accurate mass
measurements was better than 5 ppm. All reactions were per-
formed under inert conditions.
Materials
All chemicals were obtained from commercial sources. Aminals,
1,1′-methylenedipyrrolidine,16 1,1′-methylenedipiperidine,17
1,1′-methylenebis(azepane),31 N,N,N′,N’-tetramethylmethanedi-
amine,16 N,N,N′,N’-tetraethylmethanediamine,16 and N,N,N′,N’-
tetrapropyl-methanediamine31 were readily prepared in high
yields from the reaction of formaldehyde (Sigma-Aldrich,
37 wt% in H2O) with the appropriate secondary amine accord-
ing to the literature procedures. Distilled aminals were stored
under vacuum and dry atmospheres in desiccators at room
temperature. Heptamethyleneimine (Sigma-Aldrich, 98%),
acetyl chloride (AcCl, Sigma-Aldrich, 98%), acrylamide (Sigma-
Aldrich, 97%), and methacrylamide (Sigma-Aldrich, 98%) were
Fig. 5 The X-ray crystal structure of N-[(azocan-1-yl)methyl]prop-2-
enamide hydrochloride (7a·HCl) with one molecule from the asym-
metric unit shown.
Scheme 5 Synthesis of N-[(dialkylamino)methyl]acrylamides 8a–11a
and N-[(dialkylamino)methyl]methacrylamides 8b–11b from the freshly
prepared Schiﬀ base salts.
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used as received. CH2Cl2 (Sigma-Aldrich, ≥99%), CDCl3
(Sigma-Aldrich, 99.8 atom%), D2O (Sigma-Aldrich, 99.9
atom%), KOH pellets (Sigma-Aldrich, ≥85%), Na2CO3 (Sigma-
Aldrich, ≥99%), and MgSO4 (Sigma-Aldrich, ≥99.99%) were
used as received. The synthesis of N-[(morpholin-4-yl)methyl]
prop-2-enamide 1a, 2-methyl-N-[(morpholin-4-yl)methyl]prop-
2-enamide 1b, N-[(pyrrolidin-1-yl)methyl]prop-2-enamide 2a
and N-(piperidin-1-ylmethyl)prop-2-enamide 3a is included in
our recent communication.14 For Schiﬀ base salt and
monomer synthesis all solvents were freshly distilled, and the
reactions were carried out using anhydrous solvents using an
inert nitrogen atmosphere. Acetonitrile (MeCN, Sigma-Aldrich,
≥99.9%) was freshly distilled over 3 Å molecular sieves and
then CaH2 (Sigma-Aldrich, 95%) and Et2O (Et2O, Sigma-
Aldrich, ≥99.5%) were freshly distilled over Na wire and benzo-
phenone (Sigma-Aldrich, 95%).
Synthesis of N-[(cycloalkylamino)methyl]methacrylamides
using the in situ Schiﬀ base salt approach
AcCl (14.30 mL, 0.20 mol) was added over 30 min to aminal
(0.20 mol) in MeCN (40 mL) at ca. 0 °C. Methacrylamide
(17.02 g, 0.20 mol) in MeCN (40 mL) was added, and stirred at
ca. 20 °C for 2 h. Et2O (200 mL) was added and the hydro-
chloride salt of the monomer was precipitated, filtered, and
dried under vacuum. The hydrochloride salts (1b·HCl–3b·HCl)
were recrystallized, dried, and characterized. An aqueous solu-
tion of Na2CO3 (100 mL, 3 M) was added to a suspension of
the hydrochloride salt in CH2Cl2 (100 mL) and stirred for
30 min. The organic layer was separated, and the aqueous
layer was washed with CH2Cl2 (4 × 250 mL). The combined
organic extracts were dried (MgSO4), filtered, and evaporated
to dryness to give the monomer, which was recrystallized.
2-Methyl-N-[(pyrrolidin-1-yl)methyl]prop-2-enamide hydro-
chloride (2b·HCl). White solid; mp 131–133 °C (recryst. from
MeCN); 1H NMR (400 MHz, DMSO-d6) δ 1.87–1.94 (m, 7H),
3.05–3.41 (m, 4H), 4.49 (d, J 6.7 Hz, 2H), 5.55–5.57 (m, 1H),
5.92–5.94 (m, 1H), 9.33–9.36 (t, J 6.7 Hz, 1H, NH), 10.61–10.94
(brs, 1H, NH); 13C NMR (101 MHz, DMSO-d6) δ 18.4 (Me), 22.9,
50.4, 56.4, 122.0 (all CH2), 138.4 (C), 168.8 (CvO).
2-Methyl-N-[(pyrrolidin-1-yl)methyl]prop-2-enamide (2b).
(30.29 g, 90%), white solid; mp 56–58 °C (recryst. from MeCN);
vmax (neat, cm
−1) 3215, 2962, 2819, 1655, 1619, 1521 (CvO),
1450, 1362, 1356, 1299, 1208, 1134, 1046; 1H NMR (400 MHz,
CDCl3) δ 1.75–1.79 (m, 4H), 1.96 (s, 3H), 2.62 (t, J 6.4 Hz, 4H),
4.24 (dd, J 0.7, 6.2 Hz, 2H), 5.33–5.34 (m, 1H), 5.69–5.70 (m,
1H), 6.17–6.31 (brs, 1H, NH); 13C NMR (101 MHz, CDCl3)
δ 18.8 (Me), 23.7, 51.0, 58.6, 119.8 (all CH2), 140.1 (C), 168.7
(CvO); HRMS (ESI) m/z [M + H]+, C9H17N2O calcd 169.1341
observed 169.1334.
2-Methyl-N-[(piperidin-1-yl)methyl]prop-2-enamide hydro-
chloride (3b·HCl). White solid; mp 143–145 °C (recryst. from
MeCN); 1H NMR (400 MHz, DMSO-d6) δ 1.34–1.76 (m, 6H),
1.91 (s, 3H), 2.82–2.85 (m, 2H), 3.26–3.29 (m, 2H), 4.42 (d,
J 6.6 Hz, 2H), 5.56 (s, 1H), 5.92 (s, 1H), 9.13 (t, J 6.6 Hz, 1H,
NH), 10.12–10.32 (brs, 1H, NH); 13C NMR (101 MHz, DMSO-d6)
δ 18.4 (Me), 21.2, 22.1, 49.7, 59.1, 121.9 (all CH2), 138.4 (C),
168.7 (CvO).
2-Methyl-N-[(piperidin-1-yl)methyl]prop-2-enamide (3b).
(33.54 g, 92%), white solid; mp 67–69 °C (recryst. from MeCN);
vmax (neat, cm
−1) 3353, 2934, 2852, 1671 (CvO), 1655, 1615,
1453, 1453, 1440, 1368, 1333, 1306, 1158, 1110, 1034; 1H NMR
(400 MHz, CDCl3) δ 1.38–1.44 (m, 2H), 1.54–1.59 (m, 4H), 1.95
(s, 3H), 2.45–2.59 (m, 4H), 4.10 (d, J 6.4 Hz, 2H), 5.34 (s, 1H),
5.71 (s, 1H), 6.29–6.38 (brs, 1H, NH); 13C NMR (101 MHz,
CDCl3) δ 18.8 (Me), 24.2, 25.9, 51.6, 62.4, 119.8 (all CH2), 140.2
(C), 168.9 (CvO); HRMS (ESI) m/z [M + H]+, C10H19N2O calcd
183.1497 observed 183.1493.
Synthesis of 1,1′-methylenebis(azocane)
Heptamethyleneimine (15.0 g, 0.13 mol) was added over
30 min to formaldehyde (37 wt% in H2O, 6.2 mL, 0.07 mol)
with stirring at ca. 0 °C. The solution was stirred overnight at
ca. 20 °C, after which KOH pellets were added to form a satu-
rated solution, and stirring was continued for 30 min. H2O
(40 mL) was added and the mixture was extracted with Et2O
(4 × 40 mL). The organic layers were combined and washed
with H2O (3 × 20 mL), dried (MgSO4), and evaporated to
dryness. Fractional distillation under reduced pressure gave
the title compound as a colorless liquid (14.69 g, 88%); bp
138–140 °C (0.25 mmHg); vmax (neat, cm
−1) 2915, 2846, 2779,
1657, 1472, 1448, 1358, 1250, 1158, 1094, 1046, 1017; 1H NMR
(400 MHz, CDCl3) δ 1.51–1.68 (m, 20H), 2.53–2.60 (m, 8H),
3.02 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 26.1, 27.9, 28.2,
52.9, 83.8 (all CH2); HRMS (ESI) m/z [M + H]
+, C15H31N2, calcd
239.2487, observed 239.2312.
Synthesis of N,N,N′,N’-tetrabutylmethanediamine
Dibutylamine (68.00 mL, 0.40 mol) was added over 30 min to
formaldehyde (37 wt% in H2O, 15.00 mL, 0.20 mol) with stir-
ring at ca. 0 °C. The solution was stirred overnight at ca. 20 °C.
KOH pellets were added to form a saturated solution, and the
drying agent was removed by filtration. Fractional distillation
under reduced pressure gave the title compound as a colorless
liquid (45.98 g, containing about 10% of suspected (dibutyl-
amino)methanol impurity by 1H NMR); bp 112–114 °C
(0.25 mmHg); 1H NMR (400 MHz, CDCl3) δ 0.89 (t, J 7.2 Hz,
12H), 1.28 (m, 8H), 1.33–1.41 (m, 8H), 2.42 (t, J 7.3 Hz, 8H),
2.98 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 14.3 (Me), 20.9,
29.5, 52.0, 75.6 (all CH2). HRMS (ESI) m/z [M + H]
+, C17H39N2
calcd 271.3113 observed 271.3143. The title compound was
used without further purification to prepare N,N-dibutyl-
methaniminium chloride (4f ).
Synthesis of Schiﬀ base salts
AcCl (21.33 mL, 0.3 mol) was added over 30 min to a stirred
solution of aminal (0.3 mol) in Et2O (150 mL) at ca. 0 °C, and
the resulting white precipitate was stirred for an additional
30 min. Et2O (200 mL) was added and the precipitate was fil-
tered, and dried under vacuum to give the methylene Schiﬀ-
base salt (4a–4f ). Iminium salts 4a–4f were immediately used
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in addition reactions with acrylamides and methacrylamides
due to their hygroscopic nature.
1-Methylideneazepan-1-ium chloride (4a) (white solid,
43.85 g, 99%). 1-Methylideneazepan-1-ium chloride (4a) (white
solid, 43.85 g, 99%) was characterized as N-(hydroxymethyl)
azepan-1-ium chloride (5a)
1H NMR (400 MHz, D2O) δ 1.63–1.66 (m, 4H), 1.78–1.85
(brs, 4H), 3.17–3.21 (m, 4H), 4.77 (d, J 0.8 Hz, 2H); 13C NMR
(101 MHz, D2O, 1,4-dioxane added) δ 25.2, 26.6, 46.8, 82.4 (all
CH2).
1-Methylideneazocan-1-ium chloride (4b) (white solid,
47.04 g, 97%). 1-Methylideneazocan-1-ium chloride (4b) (white
solid, 47.04 g, 97%) was characterized as N-(hydroxymethyl)
azocan-1-ium chloride (5b)
1H NMR (500 MHz, D2O) δ 1.57–1.67 (m, 6H), 1.81–1.86 (m,
4H), 3.21 (t, J 5.8 Hz, 4H), 4.74 (s, 2H); 13C NMR (125 MHz,
D2O, 1,4-dioxane added) δ 23.9, 24.8, 25.2, 45.8, 82.4 (all CH2).
N,N-Dimethylmethaniminium chloride (4c)32 (white solid,
23.85 g, 85%). N,N-Dimethylmethaniminium chloride (4c)32
(white solid, 23.85 g, 85%) was characterized as hydroxy-N,N-
dimethylmethanaminium chloride (5c)
1H NMR (400 MHz, D2O) δ 2.79 (s, 6H), 4.56 (s, 2H);
13C
NMR (101 MHz, D2O, 1,4-dioxane added) δ 35.2 (Me), 82.4
(CH2).
N,N-Diethylmethaniminium chloride (4d)33 (white solid,
31.74 g, 87%). N,N-Diethylmethaniminium chloride (4d)33
(white solid, 31.74 g, 87%) was characterized as N-ethyl-N-
(hydroxymethyl)ethanaminium chloride (5d)
1H NMR (400 MHz, D2O) δ 1.23 (t, J 7.3 Hz, 6H), 3.00–3.07
(m, 4H), 4.78 (s, 2H); 13C NMR (101 MHz, D2O, 1,4-dioxane
added) δ 11.2 (Me), 42.9, 82.4 (both CH2).
N,N-Dipropylmethaniminium chloride (4e)34,35 (white solid,
40.85 g, 91%). N,N-Dipropylmethaniminium chloride (4e)34,35
(white solid, 40.85 g, 91%) was characterized as N-(hydroxy-
methyl)-N-propylpropan-1-aminium chloride (5e)
1H NMR (400 MHz, D2O) δ 0.92 (t, J 7.6 Hz, 6H), 1.65 (sext,
J 7.6 Hz, 4H), 2.95 (t, J 7.6 Hz, 4H), 4.78 (s, 2H); 13C NMR
(101 MHz, D2O, 1,4-dioxane added) δ 10.8 (Me), 19.7, 49.7,
82.4 (all CH2).
N,N-Dibutylmethaniminium chloride (4f)35 (white solid,
44.78 g, 84%). N,N-Dibutylmethaniminium chloride (4f )35
(white solid, 44.78 g, 84%) was characterized as N-butyl-N-
(hydroxymethyl)butan-1-aminium chloride (5f )
1H NMR (400 MHz, D2O) δ 0.93 (t, J 6.0 Hz, 6H), 1.39 (sext,
J 6.0 Hz, 4H), 1.66 (quint, J 6.0 Hz, 4H), 3.04 (t, J 6.0 Hz, 4H),
4.83 (s, 2H); 13C NMR (101 MHz, D2O, 1,4-dioxane added)
δ 13.4 (Me), 19.8, 28.2, 47.9, 82.4 (all CH2).
Synthesis of seven and eight-membered N-[(cycloalkylamino)-
methyl]acrylamides and N-[(cycloalkylamino)methyl]
methacrylamides
A solution of acrylamide or methacrylamide (0.03 mol) in
MeCN (10 mL) was added to a solution of freshly prepared
Schiﬀ base salt 4a or 4b (0.04 mol) in MeCN (30 mL) and
stirred at ca. 20 °C for 4 h. Et2O (200 mL) was added and the
hydrochloride salt of the monomer was precipitated, filtered,
and dried under vacuum. The hydrochloride salts (6a·HCl–
6b·HCl and 7a·HCl–7b·HCl) were recrystallized, dried, and
characterized. An aqueous solution of Na2CO3 (15 mL, 3 M)
was added to a suspension of the hydrochloride salt in CH2Cl2
(20 mL) and left to stir for an additional 30 min and extracted
with CH2Cl2 (4 × 50 mL). The organic layer was dried (MgSO4),
filtered and evaporated to dryness to give the corresponding
monomers 6a–6b and 7a–7b.
N-[(Azepan-1-yl)methyl]prop-2-enamide hydrochloride
(6a·HCl). White solid; mp 136–138 °C (recryst. from MeCN); 1H
NMR (400 MHz, DMSO-d6) δ 1.55–1.62 (m, 4H), 1.79–1.82 (m,
4H), 3.03–3.09 (m, 2H), 3.23–3.32 (m, 2H), 4.49 (d, J 6.8 Hz,
2H), 5.80 (dd, J 1.9, 10.2 Hz, 1H), 6.26 (dd, J 1.9, 17.2 Hz, 1H),
6.41 (dd, J 10.2, 17.2 Hz, 1H), 9.53 (t, J 6.8 Hz, 1H, NH),
10.46–10.63 (brs, 1H, NH); 13C NMR (101 MHz, DMSO-d6)
δ 22.9, 26.1, 51.3, 59.2, 128.2 (all CH2), 130.4 (CH), 166.2
(CvO).
N-[(Azepan-1-yl)methyl]prop-2-enamide (6a). (4.81 g, 88%)
colourless liquid; bp 134–136 °C (0.25 mmHg); vmax (neat,
cm−1) 3278, 2922, 2852, 2852, 1656 (CvO), 1623, 1539, 1452,
1405, 1365, 1309, 1227, 1133, 1080; 1H NMR (400 MHz, CDCl3)
δ 1.52–1.61 (m, 8H), 2.68 (t, J 5.6 Hz, 4H), 4.23 (d, J 6.2 Hz,
2H), 5.61 (dd, J 1.6, 10.2 Hz, 1H), 6.11 (dd, J 10.2, 17.0 Hz, 1H),
6.25 (dd, J 1.6, 17.0 Hz, 1H), 6.31–6.40 (brs, 1H, NH); 13C NMR
(101 MHz, CDCl3) δ 26.9, 28.6, 53.1, 62.6, 126.7 (all CH2), 131.1
(CH), 166.1 (CvO); HRMS (ESI) m/z [M + H]+, C10H19N2O calcd
183.1497 observed 183.1516.
N-[(Azepan-1-yl)methyl]-2-methylprop-2-enamide hydro-
chloride (6b·HCl). White solid; mp 88–90 °C (recryst. from
THF); 1H NMR (400 MHz, DMSO-d6) δ 1.53–1.64 (m, 4H),
1.79–1.81 (m, 4H), 1.91 (s, 3H), 3.02–3.15 (m, 2H), 3.23–3.30
(m, 2H), 4.46 (d, J 4.3 Hz, 2H), 5.57 (s, 1H), 5.92 (s, 1H), 9.19
(m, 1H, NH), 10.28–10.44 (brs, 1H, NH); 13C NMR (101 MHz,
DMSO-d6) δ 18.4 (Me), 22.8, 26.2, 51.4, 59.7, 122.0 (all CH2),
138.4 (C), 168.7 (CvO).
N-[(Azepan-1-yl)methyl]-2-methylprop-2-enamide (6b).
(5.36 g, 91%) colourless liquid; bp 139–141 °C (0.25 mmHg);
vmax (neat, cm
−1) 3328, 2923, 2852, 1655, 1616 (CvO), 1526,
1373, 1313, 1201, 1133, 1088, 1020; 1H NMR (400 MHz, CDCl3)
δ 1.56–1.68 (m, 8H), 1.96 (s, 3H), 2.72 (t, J 5.5 Hz, 4H), 4.24 (d,
J 6.1 Hz, 2H), 5.33 (s, 1H), 5.69 (s, 1H), 6.12–6.22 (brs, 1H,
NH); 13C NMR (101 MHz, CDCl3) δ 18.8 (Me), 27.0, 28.6, 53.2,
62.7, 119.6 (all CH2), 140.3 (C), 168.8 (CvO); HRMS (ESI) m/z
[M + H]+, C11H21N2O calcd 197.1654 observed 197.1708.
N-[(Azocan-1-yl)methyl]prop-2-enamide hydrochloride
(7a·HCl). White solid; mp 87–89 °C (recryst. from EtOAc); 1H
NMR (400 MHz, DMSO-d6) δ 1.43–1.70 (m, 6H), 1.76–1.96 (m,
4H), 3.10–3.16 (m, 2H), 3.22–3.32 (m, 2H), 4.48–4.68 (m, 2H),
5.69 (d, J 10.1 Hz, 1H), 6.25 (d, J 17.1 Hz, 1H), 6.43 (dd, J 10.1,
17.1 Hz, 1H), 9.58–9.67 (m, 1H, NH), 10.25–10.38 (brs, 1H,
NH); 13C NMR (101 MHz, DMSO-d6) δ 22.1, 24.0, 25.1, 48.8,
59.2, 128.2 (all CH2), 130.4 (CH), 166.2 (CvO).
N-[(Azocan-1-yl)methyl]prop-2-enamide (7a). (5.30 g, 90%)
colourless oil; vmax (neat, cm
−1) 3328, 2917, 2850, 1657 (CvO),
1624, 1536, 1363, 1232, 1162, 1095, 1060; 1H NMR (400 MHz,
CDCl3) δ 1.50–1.62 (m, 10H), 2.62–2.70 (m, 4H), 4.27 (d,
Paper Organic & Biomolecular Chemistry
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J 6.0 Hz, 2H), 5.65 (d, J 10.2 Hz, 1H), 5.91–6.02 (brs, 1H), 6.10
(dd, J 10.2, 17.0 Hz, 1H), 6.28 (d, J 17.0 Hz, 1H); 13C NMR
(101 MHz, CDCl3) δ 26.1, 27.7, 28.0, 51.6, 62.6, 126.7 (all CH2),
131.2 (CH), 166.0 (CvO); HRMS (ESI) m/z [M + H]+,
C11H21N2O, calcd 197.1656, observed 197.1654.
N-[(Azocan-1-yl)methyl]-2-methylprop-2-enamide hydro-
chloride (7b·HCl). White solid; mp 128–130 °C (recryst. from
EtOAc); 1H NMR (400 MHz, DMSO-d6) δ 1.46–1.75 (m, 6H),
1.81–1.99 (m, 7H), 3.07–3.18 (m, 2H), 3.23–3.35 (m, 2H),
4.45–4.53 (m, 2H), 5.70 (s, 1H), 5.93 (s, 1H), 9.17–9.27 (brs, 1H,
NH), 9.94–10.09 (brs, 1H, NH); 13C NMR (101 MHz, DMSO-d6)
δ 18.4 (Me), 22.2, 24.0, 25.0, 48.9, 59.8, 122.0 (all CH2), 138.4
(C), 168.6 (CvO).
N-[(Azocan-1-yl)methyl]-2-methylprop-2-enamide (7b).
(5.30 g, 84%) colourless oil; vmax (neat, cm
−1) 3324, 2918, 2850,
1655, 1618 (CvO), 1523, 1452, 1363, 1201, 1162, 1095, 1060;
1H NMR (400 MHz, CDCl3) δ 1.49–1.59 (m, 10H), 1.93 (s, 3H),
2.61–2.66 (m, 4H), 4.21 (t, J 4.3 Hz, 2H), 5.28 (s, 1H), 5.64 (s,
1H), 6.12–6.26 (brs, 1H, NH); 13C NMR (101 MHz, CDCl3)
δ 18.8 (Me), 26.0, 27.7, 28.0, 51.5, 62.7, 119.2 (all CH2), 140.4
(C), 168.9 (CvO); HRMS (ESI) m/z [M + H]+, C12H23N2O, calcd
211.1838, observed 211.1810.
Synthesis of N-[(dialkylamino)methyl]acrylamides and
N-[(dialkyl-amino)methyl]methacrylamides
A solution of acrylamide or methacrylamide (0.25 mol) in
MeCN (50 mL) was added to a stirred solution of freshly pre-
pared Schiﬀ base salt 4c–4f (0.25 mol) in MeCN (50 mL) and
stirred at ca. 20 °C for 3 h. An aqueous solution of Na2CO3
(150 mL, 3 M) was added and the solution was stirred for an
additional 30 min and extracted with CH2CL2 (4 × 250 mL).
The organic layer was dried (MgSO4), filtered and evaporated
to give the corresponding acrylamides 8a–11a and methacryl-
amides 8b–11b.
N-[(Dimethylamino)methyl]prop-2-enamide (8a). (22.11 g,
69%) colourless liquid; bp 64–66 °C (760 mmHg); vmax (neat,
cm−1) 3281, 2942, 2827, 2780, 1659 (CvO), 1625, 1536, 1407,
1230, 1029; 1H NMR (400 MHz, CDCl3) δ 2.24 (s, 6H), 4.05 (d,
J 6.4 Hz, 2H), 5.62 (dd, J 1.6, 10.2 Hz, 1H), 6.12 (dd, J 10.2, 17.0
Hz, 1H), 6.26 (dd, J 1.6, 17.0 Hz, 1H), 6.71–6.82 (brs, 1H); 13C
NMR (101 MHz, CDCl3) δ 41.8 (Me), 61.5, 126.0 (both CH2),
130.7 (CH), 166.2 (CvO); HRMS (ESI) m/z [M + H]+, C6H13N2O,
calcd 129.1028, observed 129.1026.
N-[(Dimethylamino)methyl]-2-methylprop-2-enamide (8b).
(32.10 g, 90%) colourless liquid, bp 60–62 °C (0.25 mmHg);
vmax (neat, cm
−1) 3323, 2942, 2827, 1658 (CvO), 1619, 1523,
1453, 1311, 1196, 1049, 1033; 1H NMR (400 MHz, CDCl3)
δ 1.92 (s, 3H), 2.23 (s, 6H), 4.03 (d, J 6.3 Hz, 2H), 5.30 (s, 1H),
5.66 (s, 1H), 6.31–6.45 (brs, 1H); 13C NMR (101 MHz, CDCl3)
δ 18.7, 42.3 (both Me), 62.2, 119.5 (both CH2), 140.1 (C), 169.0
(CvO); HRMS (ESI) m/z [M + H]+, C7H15N2O calcd 143.1184,
observed 143.1180.
N-[(Diethylamino)methyl]prop-2-enamide (9a). (32.39 g,
83%) yellow oil; bp 65–67 °C (0.25 mmHg); vmax (neat, cm
−1)
3289, 2969, 2828, 1657 (CvO), 1624, 1536, 1464, 1233, 1206,
1067; 1H NMR (400 MHz, CDCl3) δ 1.08 (t, J 7.2 Hz, 6H), 2.56
(q, J 7.2 Hz, 4H), 4.29 (d, J 6.1 Hz, 2H), 5.64 (dd, J 1.4, 10.2 Hz,
1H), 5.90–5.99 (brs, 1H), 6.09 (dd, J 10.2, 17.0 Hz, 1H), 6.28
(dd, J 1.4, 17.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 12.7
(Me), 45.4, 56.9, 126.6 (all CH2), 131.0 (CH), 166.1 (CvO);
HRMS (ESI) m/z [M + H]+, C8H17N2O, calcd 157.1341, observed
157.1337.
N-[(Diethylamino)methyl]-2-methylprop-2-enamide (9b).
(33.21 g, 78%) colourless liquid, bp 72–74 °C (0.25 mmHg);
vmax (neat, cm
−1) 3344, 2970, 2827, 1656 (CvO), 1617, 1522,
1455, 1375, 1197, 1066, 1046; 1H NMR (400 MHz, CDCl3)
δ 1.03 (t, J 7.2 Hz, 6H), 1.90 (s, 3H), 2.52 (q, J 7.2 Hz, 4H), 4.22
(d, J 6.0 Hz, 2H), 5.27 (s, 1H), 5.63 (s, 1H), 6.11–6.21 (brs, 1H);
13C NMR (101 MHz, CDCl3) δ 12.7, 18.8 (both Me), 45.4,
57.3, 119.5 (all CH2), 140.2 (C), 168.9 (CvO); HRMS (ESI) m/z
[M + H]+, C9H19N2O calcd 171.1497, observed 171.1789.
N-[(Dipropylamino)methyl]prop-2-enamide (10a). (37.80 g,
82%) colourless plates, mp 25–26 °C; vmax (neat, cm
−1) 3269,
2959, 2930, 1657 (CvO), 1623, 1550, 1457, 1246, 1185, 1069;
1H NMR (500 MHz, CDCl3) δ 0.82 (t, J 7.4 Hz, 6H), 1.44 (sext,
J 7.4 Hz, 4H), 2.39 (t, J 7.4 Hz, 4H), 4.23 (d, J 6.0 Hz, 2H), 5.58
(dd, J 1.6, 10.2 Hz, 1H), 6.11 (dd, J 10.2, 17.0 Hz, 1H), 6.22 (dd,
J 1.6, 17.0 Hz, 1H), 6.28–6.39 (brs, 1H); 13C NMR (125 MHz,
CDCl3) δ 11.9 (Me), 20.9, 54.0, 58.1, 126.5 (all CH2), 131.1 (CH),
166.1 (CvO); HRMS (ESI) m/z [M + H]+, C10H21N2O calcd
185.1654, observed 185.1663.
N-[(Dipropylamino)methyl]-2-methylprop-2-enamide (10b).
(43.62 g, 88%) colourless liquid, bp 86–88 °C (0.25 mmHg);
vmax (neat, cm
−1) 3316, 2959, 2934, 2873, 1655 (CvO), 1619,
1524, 1456, 1374, 1183, 1075, 1052; 1H NMR (400 MHz, CDCl3)
δ 0.85 (t, J 7.4 Hz, 6H), 1.46 (sext, J 7.4 Hz, 4H), 1.93 (s, 3H),
2.42 (t, J 7.4 Hz, 4H), 4.22 (d, J 6.0 Hz, 2H), 5.29 (s, 1H), 5.65 (s,
1H), 6.02–6.15 (brs, 1H); 13C NMR (101 MHz, CDCl3) δ 11.9,
18.8 (both Me), 20.9, 54.1, 58.5, 119.4 (all CH2), 140.3 (C),
168.9 (CvO); HRMS (ESI) m/z [M + H]+, C11H23N2O calcd
199.1810, observed 199.1800.
N-[(Dibutylamino)methyl]prop-2-enamide (11a). (44.56 g,
84%) colourless liquid, bp 124–126 °C (0.25 mmHg); vmax
(neat, cm−1) 3281, 3069, 2957, 2863, 1658 (CvO), 1625, 1542,
1456, 1459, 1366, 1180, 1071; 1H NMR (400 MHz, CDCl3)
δ 0.89 (t, J 7.3 Hz, 6H), 1.24–1.33 (m, 4H), 1.40–1.47 (m, 4H),
2.45 (t, J 7.5 Hz, 4H), 4.26 (d, J 6.0 Hz, 2H), 5.63 (dd, J 1.5,
10.2 Hz, 1H), 5.88–6.00 (brs, 1H), 6.10 (dd, J 10.2, 17.0 Hz, 1H),
6.27 (dd, J 1.5, 17.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 14.1
(Me), 20.7, 30.0, 51.9, 58.3, 126.7 (all CH2), 131.0 (CH), 166.0
(CvO); HRMS (ESI) m/z [M + H]+, C12H25N2O calcd 213.1967,
observed 213.1952.
N-[(Dibutylamino)methyl]-2-methylprop-2-enamide (11b).
(49.21 g, 87%) colourless liquid, bp 133–135 °C (0.25 mmHg);
vmax (neat, cm
−1) 3325, 2957, 2931, 2872, 1625 (CvO), 1525,
1456, 1374, 1296, 1179, 1083, 1034; 1H NMR (400 MHz, CDCl3)
δ 0.89 (t, J 7.4 Hz, 6H), 1.25–1.34 (m, 4H), 1.40–1.47 (m, 4H),
1.95 (s, 3H), 2.46 (t, J 7.4 Hz, 4H), 4.24 (d, J 5.9 Hz, 2H), 5.32 (s,
1H), 5.66 (s, 1H), 5.98–6.06 (brs, 1H); 13C NMR (101 MHz,
CDCl3) δ 14.1, 18.8 (both Me), 20.7, 30.0, 51.9, 58.6, 119.4 (all
CH2), 140.4 (C), 168.9 (CvO); HRMS (ESI) m/z [M + H]
+,
C13H27N2O calcd 227.2123, observed 227.2129.
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X-ray crystallographic studies
Single crystal X-ray diﬀraction data were collected using an
Oxford Diﬀraction Xcalibur system operated using the
CrysAlisPro software36 and the data collection temperature was
controlled at 150 K using a Cryojet system from Rigaku Oxford
Diﬀraction. The crystals were hygroscopic and were first coated
in cold paraﬃn oil before being transferred to the cold stream
on the diﬀractometer. The crystal structures were solved using
ShelxT version 2014/5,37 and refined using ShelxL version
2017/138 both of which were operated within the Oscail soft-
ware package.39
Crystal refinement data for 1-(hydroxymethyl)azocan-1-ium
chloride (5b). Colourless crystals, C8H18ClNO, M = 179.68,
monoclinic, space group P21/c, a = 11.3190(18), b =
10.9194(16), c = 7.7658(10) Å, α = 90, β = 90.269(13), γ = 90°, V =
959.8(2) Å3, Z = 4, T = 150.0(1) K, ρcalcd = 1.243 g cm
−3, refine-
ment of 147 parameters on 2345 independent reflections out
of 7528 measured reflections (Rint = 0.0709) led to R1 = 0.0857
(I > 2σ(I)), wR2 = 0.2182 (all data), and S = 1.119 with the
largest diﬀerence peak and hole of 0.396 and −0.398 e Å−3.
Crystal refinement data for N-[(azocan-1-yl)methyl]prop-2-
enamide hydrochloride (7a·HCl). Colourless needle crystals,
C11H21ClN2O, M = 232.75, triclinic, space group P1ˉ, a =
10.1121(7), b = 10.4420(6), c = 12.0205(14) Å, α = 95.695(8), β =
91.086(8), γ = 97.671(5)°, V = 1251.02(19) Å3, Z = 4, T = 150.0(1)
K, ρcalcd = 1.236 g cm
−3, refinement of 271 parameters on 4487
independent reflections out of 7456 measured reflections
(Rint = 0.0638) led to R1 = 0.0684 (I > 2σ(I)), wR2 = 0.2128 (all
data), and S = 0.979 with the largest diﬀerence peak and hole
of 0.852 and −0.705 e Å−3.
Crystallographic data for compounds 5b and 7a·HCl have
been deposited with the Cambridge Crystallographic Data
Centre with deposition numbers CCDC 1819145 and 1819144
respectively.†
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